Spironolactone failed to reduce major adverse cardiac effects in patients with CKD on haemodialysis Presented ByProf. Patrick Rossignol, University Hospital of Nancy, France TrialPhase 3, ALCHEMIST ConferenceASN 2023 TypeNews article 28 November 2023 15:18